News for Industry

(New York, NY) Many unqualified stem cell clinics and physicians are making false claims of cure for a number of conditions without scientific study or supporting data. This news segment helps patients identify qualified physicians and stem cell centers.

(Madison, WI) Fujifilm Cellular Dynamics announced their opening of a $21 million “cleanroom” to manufacture stem cells for human clinical trials.

(San Antonio, TX) GenCure’s bio manufacturing team announced a successful production run where human mesenchymal stem cells were expanded in an 80 Liter bioreactor.  This type of scalability will help many patients going forward.

(San Francisco, CA) The California Institute of Regenerative Medicine “CIRM” is gearing up for another multibillion-dollar bond raise.  President and CEO Maria Millan, MD states that CIRM continues “… to play an extremely important role of boldly investigating early and de-risking these…” stem cell therapy protocols.

(New York City, NY) The New York State Attorney General Letitia James filed a lawsuit against a Park Avenue stem cell facility for misrepresenting scientific justification of their regenerative medicine procedures.

(Silver Spring, MD) The FDA released a second guidance document which details a range of medical devices that may be used in conjunction with regenerative medicine advanced therapies (RMAT).

(Washington, DC) The CDC analyzes 12 cases of bacterially contaminated umbilical cord stem cells and examines unopened vials, all from the same manufacturer.

(Madison, WI) Stem cell scientists at UW-Madison are utilizing a new gene editing technology to increase the demand for regenerative medicine discovery and services.

(Alexandria, VA) A global analysis of the cancer stem cell market including manufacturing, challenges, trends or and forecasts.